BDO Wealth Advisors’s Epizyme, Inc EPZM Stock Holding History

BDO Wealth Advisors’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-5,000	Closed	-$7K	–	1171
2022 Q2	$7K	Buy	+5,000	New	+$3.67K	﹤0.01%	754
2019 Q1	–	Sell	-510	Closed	-$3K	–	683
2018 Q4	$3K	Buy	510 +110	+28%	+$840	﹤0.01%	482
2018 Q3	$4K	Sell	400 -250	-38%	-$2.85K	﹤0.01%	524
2018 Q2	$9K	Buy	+650	New	+$10.1K	﹤0.01%	476

Other funds holding EPZM

Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

BDO Wealth Advisors's EPZM Position: Q3 2022 in Review

BDO Wealth Advisors sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 5,000 shares — an estimated $7K sold.

BDO Wealth Advisors first reported a position in EPZM in Q2 2018 and held it in 4 quarters. The position peaked at $9K in Q2 2018. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.

BDO Wealth Advisors reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
BDO Wealth Advisors sold 5,000 Epizyme, Inc shares in Q3 2022, an estimated $7K.
BDO Wealth Advisors first reported a position in Epizyme, Inc in Q2 2018 and held it in 4 quarters.
BDO Wealth Advisors's Epizyme, Inc position peaked at $9K in Q2 2018.
0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.

Based on BDO Wealth Advisors's 13F filing for Q3 2022, filed 1 Nov 2022.